ReviewFrontiers in pediatrics2026
Ferroptosis in necrotizing enterocolitis: iron overload-driven intestinal injury and mechanistic insights.
Review in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Necrotizing enterocolitis (NEC) is a devastating gastrointestinal emergency that primarily affects preterm infants and remains associated with high mortality and significant long-term morbidity. Despite decades of research, the precise mechanisms underlying NEC pathogenesis remain incompletely understood, and effective targeted preventive or therapeutic strategies are limited. Ferroptosis, a regulated form of cell death driven by iron-dependent lipid peroxidation, has recently emerged as an important contributor to intestinal epithelial injury in NEC. Preterm infants are particularly vulnerable to ferroptosis due to immature iron homeostasis, frequent exposure to exogenous iron through supplementation and blood transfusion, heightened oxidative stress, and insufficient antioxidant capacity. Accumulating experimental evidence indicates that iron overload promotes excessive lipid peroxidation, glutathione depletion, and inactivation of key antioxidant enzymes, leading to ferroptotic death of intestinal epithelial cells. This process compromises intestinal barrier integrity, amplifies inflammatory signaling, and interacts with gut microbiota dysbiosis, thereby accelerating NEC progression. In this review, we summarize current advances in understanding the role of ferroptosis in NEC, with an emphasis on iron overload as a central upstream driver and ferroptosis as a convergent execution pathway linking multiple pathogenic factors. We discuss evidence from experimental and translational studies, explore the crosstalk between ferroptosis, inflammation, and the gut microbiota, and outline potential therapeutic implications of targeting ferroptosis. A ferroptosis-centered framework may provide novel insights into NEC pathogenesis and guide future mechanistic and translational research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.